:: Volume 10, Issue 3 (Int J Mol Cell Med (In Press) 2021) ::
Int J Mol Cell Med 2021, 10(3): 0-0 Back to browse issues page
Role of mTOR Complex 1 Signaling Pathway in the Pathogenesis of Diabetes Complications; A Mini Review
Amir Yarahmadi1 , Negar Azarpira2 , Zohreh Mostafavi-Pour 3
1- Department of Biochemistry, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
2- Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
3- Department of Biochemistry, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. , zmostafavipour88@yahoo.co.uk
Abstract:   (188 Views)
The mammalian target of rapamycin (mTOR) is an evolutionarily conserved serine/threonine-protein kinase that senses and combines various environmental signals to regulate the growth and homeostasis of human cells. This signaling pathway synchronizes many critical cellular processes and is involved in an increasing number of pathological conditions such as diabetes, cancer, obesity, and metabolic syndrome. Here, we review different complications of diabetes that are associated with mTOR complex 1 imbalance. We further discuss pharmacological approaches to treat diabetes complications linked to mTOR deregulation.
Keywords: Diabetes, complications, mTOR, mTOR complex 1, signaling
Full-Text [PDF 272 kb]   (26 Downloads)    
Type of Study: Mini-review | Subject: Clinical Biochemistry
Received: 2021/07/24 | Accepted: 2021/11/15 | Published: 2021/08/19


XML     Print



Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 10, Issue 3 (Int J Mol Cell Med (In Press) 2021) Back to browse issues page